11th Alzheimer’s & Parkinson’s Drug Development
Programme du congrès
Lieu : San Francisco
Pays : Etats-Unis
Langue : ENG
Date de début :
Date de fin :
https://alzheimers-parkinsons-summit.com/
Spécialités : Gériatrie , Neurologie
Heading to sunny San Francisco for the first time, the 11th Alzheimer’s & Parkinson’s Drug Development Summit is the only-industry-focused event dedicated to overcoming the challenges and showcasing the opportunities of targeting Alzheimer’s and Parkinson’s Disease.
Previously known as the Neurodegenerative Drug Development Summit, don’t miss your only opportunity to hear about the latest clinical pipeline progressions in 2022, learn new insights into neurodegenerative disease mechanisms for new target identification, explore the latest advances in neurological biomarkers and how to incorporate them into clinical trials successfully, and discover the next generation in-vitro and in-vivo preclinical models for safety and efficacy testing.